Skip to main content
SpringerLink
Log in

Adalimumab

No response: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Eurelings LEM, et al. Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of Therapy. American Journal of Ophthalmology 240: 194-204, Aug 2022. Available from: URL: https://www.elsevier.com/locate/ajo

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1937, 22 (2022). https://doi.org/10.1007/s40278-022-29702-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-29702-7

Search

Navigation